These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38713312)

  • 1. Content Validity of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Instrument in Spinocerebellar Ataxia.
    Potashman M; Rudell K; Pavisic I; Suminski N; Doma R; Heinrich M; Abetz-Webb L; Beiner MW; Kuo SH; Rosenthal LS; Zesiwicz T; Fife TD; van de Warrenburg BP; Ristori G; Synofzik M; Perlman S; Schmahmann JD; L'Italien G
    Cerebellum; 2024 Oct; 23(5):2012-2027. PubMed ID: 38713312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia.
    Potashman M; Popoff E; Powell L; Mackenzie A; Beiner MW; Coric V; Schmahmann J; L'Italien G
    Cerebellum; 2024 Oct; 23(5):2095-2108. PubMed ID: 38865059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
    Petit E; Schmitz-Hübsch T; Coarelli G; Jacobi H; Heinzmann A; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Pulst SM; Subramony SH; Ewenczyk C; Brice A; Durr A; Klockgether T; Ashizawa T; Tezenas du Montcel S
    J Neurol; 2024 Jul; 271(7):3743-3753. PubMed ID: 38822840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of SCACOMS, a Composite Scale for Assessing Disease Progression and Treatment Effects in Spinocerebellar Ataxia.
    L'Italien G; Popoff E; Rogula B; Powell L; Potashman M; Dickson S; O'Keefe P; Beiner M; Coric V; Perlman S; Schmahmann JD; Hendrix S
    Cerebellum; 2024 Oct; 23(5):2028-2041. PubMed ID: 38710966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Measures of Postural Sway Quantify Balance Deficits in Spinocerebellar Ataxia.
    Shah VV; Muzyka D; Jagodinsky A; McNames J; Casey H; El-Gohary M; Sowalsky K; Safarpour D; Carlson-Kuhta P; Schmahmann JD; Rosenthal LS; Perlman S; Horak FB; Gomez CM
    Mov Disord; 2024 Apr; 39(4):663-673. PubMed ID: 38357985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
    Tanguy Melac A; Mariotti C; Filipovic Pierucci A; Giunti P; Arpa J; Boesch S; Klopstock T; Müller Vom Hagen J; Klockgether T; Bürk K; Schulz JB; Reetz K; Pandolfo M; Durr A; Tezenas du Montcel S;
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):559-565. PubMed ID: 29279305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait characteristics and clinical relevance of hereditary spinocerebellar ataxia on deep learning.
    Jin L; Lv W; Han G; Ni L; Sun D; Hu X; Cai H
    Artif Intell Med; 2020 Mar; 103():101794. PubMed ID: 32143799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors.
    Zhou H; Nguyen H; Enriquez A; Morsy L; Curtis M; Piser T; Kenney C; Stephen CD; Gupta AS; Schmahmann JD; Vaziri A
    Neurol Sci; 2022 Apr; 43(4):2589-2599. PubMed ID: 34664180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.
    Klinke I; Minnerop M; Schmitz-Hübsch T; Hendriks M; Klockgether T; Wüllner U; Helmstaedter C
    Cerebellum; 2010 Sep; 9(3):433-42. PubMed ID: 20502998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of different rating instruments in spinocerebellar ataxia patients.
    Schmitz-Hübsch T; Fimmers R; Rakowicz M; Rola R; Zdzienicka E; Fancellu R; Mariotti C; Linnemann C; Schöls L; Timmann D; Filla A; Salvatore E; Infante J; Giunti P; Labrum R; Kremer B; van de Warrenburg BP; Baliko L; Melegh B; Depondt C; Schulz J; du Montcel ST; Klockgether T
    Neurology; 2010 Feb; 74(8):678-84. PubMed ID: 20177122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
    Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
    Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
    Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Evaluation of Stance as a Sensitive Biomarker of Postural Ataxia Development in Preclinical SCA1 Mutation Carriers.
    Sobanska A; Czerwosz L; Sulek A; Rola R; Stepniak I; Rakowicz M
    Cerebellum; 2024 Oct; 23(5):1882-1891. PubMed ID: 38492164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.